{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T02:31:52Z","timestamp":1748399512764,"version":"3.28.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chirurgie"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s00104-023-01973-z","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T15:02:33Z","timestamp":1697554953000},"page":"122-128","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Individualisierte kurative Therapie bei malignen Erkrankungen durch Lebertransplantation","Individualized curative treatment for malignant diseases through liver transplantation"],"prefix":"10.1007","volume":"95","author":[{"given":"Laura","family":"Schwenk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Falk","family":"Rauchfu\u00df","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aladdin","family":"Ali-Deeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Dondorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Rohland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Ardelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Utz","family":"Settmacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,17]]},"reference":[{"key":"1973_CR1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00432-021-03665-9","volume":"148","author":"ABH Bhatti","year":"2022","unstructured":"Bhatti\u00a0ABH, Naqvi\u00a0W, Khan\u00a0NY et\u00a0al (2022) Living donor liver transplantation for advanced hepatocellular carcinoma including macrovascular invasion. J\u00a0Cancer Res Clin Oncol 148:245\u2013253","journal-title":"J Cancer Res Clin Oncol"},{"key":"1973_CR2","unstructured":"Bundes\u00e4rztekammer (2023) Richtlinie gem. \u00a7 16 Abs. 1 S.\u00a01 Nrn. 2 und 5 TPG f\u00fcr die Wartelistenf\u00fchrung und Organvermittlung zur Lebertransplantation"},{"key":"1973_CR3","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/SLA.0000000000003801","volume":"273","author":"WA Cambridge","year":"2021","unstructured":"Cambridge\u00a0WA, Fairfield\u00a0C, Powell\u00a0JJ et al (2021) Meta-analysis and meta-regression of survival after liver transplantation for unresectable perihilar cholangiocarcinoma. Ann Surg 273:240\u2013250","journal-title":"Ann Surg"},{"key":"1973_CR4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12876-018-0912-x","volume":"18","author":"KM Chan","year":"2018","unstructured":"Chan\u00a0KM, Tsai\u00a0CY, Yeh\u00a0CN et\u00a0al (2018) Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence. BMC Gastroenterol 18:180","journal-title":"BMC Gastroenterol"},{"key":"1973_CR5","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jamcollsurg.2016.05.019","volume":"223","author":"A Doussot","year":"2016","unstructured":"Doussot\u00a0A, Gonen\u00a0M, Wiggers\u00a0JK et al (2016) Recurrence patterns and disease-free survival after resection of intrahepatic cholangiocarcinoma: preoperative and postoperative prognostic models. J\u00a0Am Coll Surg 223:493\u2013505.e2","journal-title":"J Am Coll Surg"},{"key":"1973_CR6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1097\/SLA.0b013e31820508f1","volume":"253","author":"D Dubay","year":"2011","unstructured":"Dubay\u00a0D, Sandroussi\u00a0C, Sandhu\u00a0L et\u00a0al (2011) Liver transplantation for advanced hepatocellular carcinoma using poor tumor differentiation on biopsy as an exclusion criterion. Ann Surg 253:166\u2013172","journal-title":"Ann Surg"},{"key":"1973_CR7","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1002\/bjs.10769","volume":"105","author":"S Dueland","year":"2018","unstructured":"Dueland\u00a0S, Foss\u00a0A, Solheim\u00a0JM et al (2018) Survival following liver transplantation for liver-only colorectal metastases compared with hepatocellular carcinoma. Br J Surg 105:736\u2013742","journal-title":"Br J Surg"},{"key":"1973_CR8","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/SLA.0000000000003404","volume":"271","author":"S Dueland","year":"2020","unstructured":"Dueland\u00a0S, Syversveen\u00a0T, Solheim\u00a0JM et al (2020) Survival following liver transplantation for patients with nonresectable liver-only colorectal metastases. Ann Surg 271:212\u2013218","journal-title":"Ann Surg"},{"key":"1973_CR9","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1053\/j.gastro.2012.05.052","volume":"143","author":"C Duvoux","year":"2012","unstructured":"Duvoux\u00a0C, Roudot-Thoraval\u00a0F, Decaens\u00a0T et al (2012) Liver transplantation for hepatocellular carcinoma: a\u00a0model including \u03b1\u2011fetoprotein improves the performance of Milan criteria. Gastroenterology 143:986\u2013994.e3 (quiz e914\u2013985)","journal-title":"Gastroenterology"},{"key":"1973_CR10","doi-asserted-by":"crossref","unstructured":"Eshmuminov D, Studer DJ, Lopez Lopez V et\u00a0al (2022) Controversy over liver transplantation or resection for neuroendocrine liver metastasis: tumor biology cuts the deal. Ann Surg","DOI":"10.1097\/SLA.0000000000005663"},{"key":"1973_CR11","doi-asserted-by":"publisher","first-page":"9531925","DOI":"10.1155\/2018\/9531925","volume":"2018","author":"A Gorgen","year":"2018","unstructured":"Gorgen\u00a0A, Muaddi\u00a0H, Zhang\u00a0W et\u00a0al (2018) The new era of transplant oncology: liver transplantation for nonresectable colorectal cancer liver metastases. Can J Gastroenterol Hepatol 2018:9531925","journal-title":"Can J Gastroenterol Hepatol"},{"key":"1973_CR12","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1007\/s00268-014-2647-3","volume":"38","author":"M Gr\u0105t","year":"2014","unstructured":"Gr\u0105t\u00a0M, Kornasiewicz\u00a0O, Lewandowski\u00a0Z et al (2014) Combination of morphologic criteria and \u03b1\u2011fetoprotein in selection of patients with hepatocellular carcinoma for liver transplantation minimizes the problem of posttransplant tumor recurrence. World J Surg 38:2698\u20132707","journal-title":"World J Surg"},{"key":"1973_CR13","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1002\/lt.23904","volume":"20","author":"B Hameed","year":"2014","unstructured":"Hameed\u00a0B, Mehta\u00a0N, Sapisochin\u00a0G et al (2014) Alpha-fetoprotein level >\u202f1000\u202fng\/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria. Liver Transpl 20:945\u2013951","journal-title":"Liver Transpl"},{"key":"1973_CR14","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1097\/01.tp.0000253551.43583.d1","volume":"82","author":"JK Heimbach","year":"2006","unstructured":"Heimbach\u00a0JK, Gores\u00a0GJ, Haddock\u00a0MG et\u00a0al (2006) Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma. Transplantation 82:1703\u20131707","journal-title":"Transplantation"},{"key":"1973_CR15","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1002\/hep.31210","volume":"72","author":"A Kardashian","year":"2020","unstructured":"Kardashian\u00a0A, Florman\u00a0SS, Haydel\u00a0B et\u00a0al (2020) Liver transplantation outcomes in a\u00a0U.S. multicenter cohort of 789 patients with hepatocellular carcinoma presenting beyond Milan criteria. Hepatology 72:2014\u20132028","journal-title":"Hepatology"},{"key":"1973_CR16","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1159\/000327577","volume":"29","author":"M Kudo","year":"2011","unstructured":"Kudo\u00a0M, Izumi\u00a0N, Kokudo\u00a0N et al (2011) Management of hepatocellular carcinoma in Japan: consensus-based clinical practice guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis 29:339\u2013364","journal-title":"Dig Dis"},{"key":"1973_CR17","first-page":"77","volume":"4","author":"Q Lee","year":"2021","unstructured":"Lee\u00a0Q, Yu\u00a0X, Yu\u00a0W (2021) The value of PIVKA-II versus AFP for the diagnosis and detection of postoperative changes in hepatocellular carcinoma. J\u00a0Interv Med 4:77\u201381","journal-title":"J Interv Med"},{"key":"1973_CR18","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1159\/000507887","volume":"9","author":"S Lee","year":"2020","unstructured":"Lee\u00a0S, Kim\u00a0KW, Song\u00a0GW et\u00a0al (2020) The real impact of bridging or downstaging on survival outcomes after liver transplantation for hepatocellular carcinoma. Liver Cancer 9:721\u2013733","journal-title":"Liver Cancer"},{"key":"1973_CR19","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S2468-1253(18)30045-1","volume":"3","author":"KE Lunsford","year":"2018","unstructured":"Lunsford\u00a0KE, Javle\u00a0M, Heyne\u00a0K et al (2018) Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a\u00a0prospective case-series. Lancet Gastroenterol Hepatol 3:337\u2013348","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1973_CR20","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.jhep.2007.07.004","volume":"47","author":"V Mazzaferro","year":"2007","unstructured":"Mazzaferro\u00a0V, Pulvirenti\u00a0A, Coppa\u00a0J (2007) Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation? J\u00a0Hepatol 47:460\u2013466","journal-title":"J Hepatol"},{"key":"1973_CR21","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJM199603143341104","volume":"334","author":"V Mazzaferro","year":"1996","unstructured":"Mazzaferro\u00a0V, Regalia\u00a0E, Doci\u00a0R et\u00a0al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N\u00a0Engl J Med 334:693\u2013699","journal-title":"N Engl J Med"},{"key":"1973_CR22","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1111\/ajt.13831","volume":"16","author":"V Mazzaferro","year":"2016","unstructured":"Mazzaferro\u00a0V, Sposito\u00a0C, Coppa\u00a0J et al (2016) The long-term benefit of liver transplantation for hepatic metastases from neuroendocrine tumors. Am J Transplant 16:2892\u20132902","journal-title":"Am J Transplant"},{"key":"1973_CR23","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1097\/TP.0000000000003174","volume":"104","author":"N Mehta","year":"2020","unstructured":"Mehta\u00a0N, Bhangui\u00a0P, Yao\u00a0FY et\u00a0al (2020) Liver transplantation for hepatocellular carcinoma. Working group report from the ILTS transplant oncology consensus conference. Transplantation 104:1136\u20131142","journal-title":"Transplantation"},{"key":"1973_CR24","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.cgh.2017.11.037","volume":"16","author":"N Mehta","year":"2018","unstructured":"Mehta\u00a0N, Guy\u00a0J, Frenette\u00a0CT et al (2018) Excellent outcomes of liver transplantation following down-staging of hepatocellular carcinoma to within Milan criteria: a\u00a0multicenter study. Clin Gastroenterol Hepatol 16:955\u2013964","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1973_CR25","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1097\/00007890-200004270-00019","volume":"69","author":"CG Meyer","year":"2000","unstructured":"Meyer\u00a0CG, Penn\u00a0I, James\u00a0L (2000) Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 69:1633\u20131637","journal-title":"Transplantation"},{"key":"1973_CR26","first-page":"1567","volume":"23","author":"F M\u00fchlbacher","year":"1991","unstructured":"M\u00fchlbacher\u00a0F, Huk\u00a0I, Steininger\u00a0R et\u00a0al (1991) Is orthotopic liver transplantation a\u00a0feasible treatment for secondary cancer of the liver? Transplant Proc 23:1567\u20131568","journal-title":"Transplant Proc"},{"key":"1973_CR27","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1002\/lt.20837","volume":"12","author":"G Otto","year":"2006","unstructured":"Otto\u00a0G, Herber\u00a0S, Heise\u00a0M et\u00a0al (2006) Response to transarterial chemoembolization as a\u00a0biological selection criterion for liver transplantation in hepatocellular carcinoma. Liver Transpl 12:1260\u20131267","journal-title":"Liver Transpl"},{"key":"1973_CR28","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/BF01659064","volume":"15","author":"B Ringe","year":"1991","unstructured":"Ringe\u00a0B, Pichlmayr\u00a0R, Wittekind\u00a0C et\u00a0al (1991) Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg 15:270\u2013285","journal-title":"World J Surg"},{"key":"1973_CR29","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/SLA.0000000000005726","volume":"277","author":"U Settmacher","year":"2023","unstructured":"Settmacher\u00a0U, Ali-Deeb\u00a0A, Coubeau\u00a0L et al (2023) Auxilliary liver transplantation according to the RAPID procedure in noncirrhotic patients: technical aspects and early outcomes. Ann Surg 277:305\u2013312","journal-title":"Ann Surg"},{"key":"1973_CR30","doi-asserted-by":"publisher","first-page":"E491","DOI":"10.1111\/j.1399-0012.2011.01463.x","volume":"25","author":"K Shirabe","year":"2011","unstructured":"Shirabe\u00a0K, Taketomi\u00a0A, Morita\u00a0K et al (2011) Comparative evaluation of expanded criteria for patients with hepatocellular carcinoma beyond the Milan criteria undergoing living-related donor liver transplantation. Clin Transplant 25:E491\u2013E498","journal-title":"Clin Transplant"},{"key":"1973_CR31","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1159\/000106908","volume":"25","author":"Y Takada","year":"2007","unstructured":"Takada\u00a0Y, Ito\u00a0T, Ueda\u00a0M et\u00a0al (2007) Living donor liver transplantation for patients with HCC exceeding the Milan criteria: a\u00a0proposal of expanded criteria. Dig Dis 25:299\u2013302","journal-title":"Dig Dis"},{"key":"1973_CR32","doi-asserted-by":"crossref","unstructured":"Berg T, Bruns T, Welker M\u2011W, Weism\u00fcller T, Trebicka J, Tacke F, Strnad P, Sterneck M, Settmacher U, Seehofer D, Schott E, Schnitzbauer AA, Schmidt HH, J\u00fcRgen Schlitt H, Pratschke J, Pascher A, Neumann U, Manekeller S, Lammert F, Klein I, Kirchner G, Guba M, Glanemann M, Engelmann C, Canbay AE, Braun F, Berg C, Bechstein WO, Becker T, Trautwein C (2023) S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft f\u00fcr Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft f\u00fcr Allgemein- und Viszeralchirurgie (DGAV).","DOI":"10.1055\/a-2255-7246"},{"key":"1973_CR33","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1002\/lt.21334","volume":"13","author":"S Todo","year":"2007","unstructured":"Todo\u00a0S, Furukawa\u00a0H, Tada\u00a0M (2007) Extending indication: role of living donor liver transplantation for hepatocellular carcinoma. Liver Transpl 13:S48\u2013S54","journal-title":"Liver Transpl"},{"key":"1973_CR34","doi-asserted-by":"publisher","first-page":"399","DOI":"10.21037\/hbsn.2016.08.05","volume":"5","author":"J Togashi","year":"2016","unstructured":"Togashi\u00a0J, Akamastu\u00a0N, Kokudo\u00a0N (2016) Living donor liver transplantation for hepatocellular carcinoma at the University of Tokyo Hospital. Hepatobiliary Surg Nutr 5:399\u2013407","journal-title":"Hepatobiliary Surg Nutr"},{"key":"1973_CR35","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1097\/SLA.0b013e3181896278","volume":"248","author":"M Vivarelli","year":"2008","unstructured":"Vivarelli\u00a0M, Cucchetti\u00a0A, La Barba\u00a0G et\u00a0al (2008) Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence. Ann Surg 248:857\u2013862","journal-title":"Ann Surg"},{"key":"1973_CR36","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1055\/a-1589-7585","volume":"60","author":"S Voesch","year":"2022","unstructured":"Voesch\u00a0S, Bitzer\u00a0M, Bl\u00f6dt\u00a0S et\u00a0al (2022) Z\u00a0Gastroenterol 60:e131\u2013e185","journal-title":"Z Gastroenterol"},{"key":"1973_CR37","doi-asserted-by":"publisher","first-page":"8868370","DOI":"10.1155\/2021\/8868370","volume":"2021","author":"F Xu","year":"2021","unstructured":"Xu\u00a0F, Zhang\u00a0L, He\u00a0W et al (2021) The diagnostic value of serum PIVKA-II alone or in combination with AFP in Chinese hepatocellular carcinoma patients. Dis Markers 2021:8868370","journal-title":"Dis Markers"},{"key":"1973_CR38","doi-asserted-by":"publisher","first-page":"726213","DOI":"10.3389\/fonc.2021.726213","volume":"11","author":"Y Yang","year":"2021","unstructured":"Yang\u00a0Y, Li\u00a0G, Lu\u00a0Z et al (2021) Progression of prothrombin induced by vitamin\u00a0K absence-II in hepatocellular carcinoma. Front Oncol 11:726213","journal-title":"Front Oncol"},{"issue":"Suppl 2","key":"1973_CR39","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1002\/lt.22335","volume":"17","author":"FY Yao","year":"2011","unstructured":"Yao\u00a0FY, Breitenstein\u00a0S, Broelsch\u00a0CE et al (2011) Does a\u00a0patient qualify for liver transplantation after the down-staging of hepatocellular carcinoma? Liver Transpl 17(Suppl 2):S109\u2013S116","journal-title":"Liver Transpl"},{"key":"1973_CR40","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1097\/TP.0b013e31816b67e4","volume":"85","author":"SS Zheng","year":"2008","unstructured":"Zheng\u00a0SS, Xu\u00a0X, Wu\u00a0J et\u00a0al (2008) Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation 85:1726\u20131732","journal-title":"Transplantation"},{"key":"1973_CR41","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1097\/TP.0000000000003539","volume":"105","author":"IA Ziogas","year":"2021","unstructured":"Ziogas\u00a0IA, Giannis\u00a0D, Economopoulos\u00a0KP et al (2021) Liver transplantation for intrahepatic cholangiocarcinoma: a\u00a0meta-analysis and meta-regression of survival rates. Transplantation 105:2263\u20132271","journal-title":"Transplantation"}],"container-title":["Die Chirurgie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-023-01973-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00104-023-01973-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-023-01973-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:07:16Z","timestamp":1730333236000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00104-023-01973-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,17]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1973"],"URL":"https:\/\/doi.org\/10.1007\/s00104-023-01973-z","relation":{},"ISSN":["2731-6971","2731-698X"],"issn-type":[{"type":"print","value":"2731-6971"},{"type":"electronic","value":"2731-698X"}],"subject":[],"published":{"date-parts":[[2023,10,17]]},"assertion":[{"value":"22 September 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"L.\u00a0Schwenk, F.\u00a0Rauchfu\u00df, A.\u00a0Ali-Deeb, F.\u00a0Dondorf, O.\u00a0Rohland, M.\u00a0Ardelt und U.\u00a0Settmacher geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}